Australian pharmacies now stock naloxone widely, knowledge drives supply
This national survey quantifies how pharmacist knowledge, attitudes, and pharmacy service context predict naloxone stocking under Australia's Take Home Naloxone (THN) program, informing harm-reduction workforce strategy.
📅 Journal publication: Dec 2026(online Sep 5, 2026)·Last updated: Oct 6, 2026
naloxoneopioid overdoseharm reductioncommunity pharmacyTake Home Naloxoneopioid agonist treatmentcross-sectional surveyAustraliapharmacist practiceBehavioral Health / Addiction Medicine
Background Information
Positive pharmacist attitudes drive naloxone availability in Australia.
Understanding pharmacists' roles can improve naloxone provision and overdose prevention strategies in the community. 73.2% of pharmacies stocked naloxone, with positive attitudes and knowledge significantly linked to its provision. Barriers included time and training issues. Despite positive findings, efforts to address barriers like lack of time and training could further enhance naloxone access in community pharmacies. Increasing naloxone education and support for pharmacists may enhance overdose prevention efforts.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Picco L, Jung M, Laing R, Bratberg J, Sproule B, Nielsen S
Citation:Picco L, Jung M, Laing R, et al. Knowledge, attitudes and practices among Australian community pharmacists towards naloxone and overdose prevention: a national cross-sectional study. International journal of clinical pharmacy. 2026;48(6):2418-2428. doi:10.1007/s11096-026-02219-8